Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease

Trends in Genetics

Volumn 23, Issue 7, 2007, Pages 326-333

  Moyes, David ^a   Griffiths, David J ^b   Venables, Patrick J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; POPULATION; PRIORITY JOURNAL; RETROVIRUS; RISK FACTOR; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AUTOIMMUNE DISEASES; ENDOGENOUS RETROVIRUSES; EVOLUTION, MOLECULAR; GENE FREQUENCY; GENOME, HUMAN; HUMANS; MODELS, GENETIC; NEOPLASMS; POLYMORPHISM, GENETIC; TERMINAL REPEAT SEQUENCES; VIRUS INTEGRATION;

HUMAN ENDOGENOUS RETROVIRUSES; PRIMATES;

EID: 34250813062     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2007.05.004     Document Type: Article

References (70)

1. Bannert N., and Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U. S. A. 101 Suppl. 2 (2004) 14572-14579
2. Gifford R., and Tristem M. The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26 (2003) 291-315
3. Löwer R. The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol. 7 (1999) 350-356
4. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
5. Palmarini M., et al. Endogenous betaretroviruses of sheep: teaching new lessons in retroviral interference and adaptation. J. Gen. Virol. 85 (2004) 1-13
6. Roy-Burman P. Endogenous env elements: partners in generation of pathogenic feline leukemia viruses. Virus Genes 11 (1995) 147-161
7. Tarlinton R.E., et al. Retroviral invasion of the koala genome. Nature 442 (2006) 79-81
8. Lavie L., et al. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J. Virol. 79 (2005) 876-883
9. Blond J.L., et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 74 (2000) 3321-3329
10. Mallet F., et al. The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1731-1736
11. Blaise S., et al. Functional characterization of two newly identified Human Endogenous Retrovirus coding envelope genes. Retrovirology 2 (2005) 19
12. Dewannieux M., et al. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J. Virol. 79 (2005) 15573-15577
13. Dunlap K.A., et al. Endogenous retroviruses regulate periimplantation placental growth and differentiation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14390-14395
14. Prudhomme S., et al. Endogenous retroviruses and animal reproduction. Cytogenet. Genome Res. 110 (2005) 353-364
15. Campillos M., et al. Computational characterization of multiple Gag-like human proteins. Trends Genet. 22 (2006) 585-589
16. Denne M., et al. Physical and functional interaction of human endogenous retrovirus proteins Np9 and Rec with the promyelocytic leukemia zinc finger protein. J Virol. (2007) 10.1128/JVI.02771-06 (jvi.asm.org)
17. Galli U.M., et al. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 24 (2005) 3223-3228
18. Wang-Johanning F., et al. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int. J. Cancer 120 (2006) 81-90
19. Muster T., et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res. 63 (2003) 8735-8741
20. Buscher K., et al. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res. 65 (2005) 4172-4180
21. Hirschl S., et al. Sequence variability of retroviral particles derived from human melanoma cells melanoma-associated retrovirus. Virus Res. 123 (2007) 211-215
22. Hervé C.A., et al. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin. Exp. Immunol. 128 (2002) 75-82
23. Antony J.M. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7 (2004) 1088-1095
24. Rolland A., et al. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis. J. Neuroimmunol. 160 (2005) 195-203
25. Perron H., et al. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J. Neurovirol. 11 (2005) 23-33
26. Green J.E., et al. Exocrinopathy resembling Sjogren's syndrome in HTLV-1 tax transgenic mice. Nature 341 (1989) 72-74
27. Garry R.F., et al. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250 (1990) 1127-1129
28. Price E.J., and Venables P.J. The etiopathogenesis of Sjögren's syndrome. Semin. Arthritis Rheum. 25 (1995) 117-133
29. Ehlhardt S., et al. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J. Rheumatol. 33 (2006) 16-23
30. Sicat J., et al. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J. Rheumatol. 32 (2005) 1821-1831
31. Moles J.P., et al. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. Br. J. Dermatol. 153 (2005) 83-89
32. Nelson P.N., et al. Demystified: human endogenous retroviruses. Mol. Pathol. 56 (2003) 11-18
33. Marguerat S., et al. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes. Diabetes 53 (2004) 852-854
34. Magistrelli C., et al. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 49 (1999) 829-834
35. Dangel A.W., et al. The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 40 (1994) 425-436
36. Mack M., et al. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 56 (2004) 321-332
37. Turner G., et al. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11 (2001) 1531-1535
38. Belshaw R., et al. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J. Virol. 79 (2005) 12507-12514
39. Hughes J.F., and Coffin J.M. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1668-1672
40. Macfarlane C., and Simmonds P. Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J. Mol. Evol. 59 (2004) 642-656
41. Lazo P.A., et al. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 170-173
42. Moyes D.L., et al. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86 (2005) 337-341
43. Burmeister T., et al. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res. Hum. Retroviruses 20 (2004) 1223-1229
44. Otowa T., et al. Insertional polymorphism of endogenous retrovirus HERV-K115 in schizophrenia. Neurosci. Lett. 408 (2006) 226-229
45. Belshaw R., et al. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4894-4899
46. Dewannieux M., et al. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16 (2006) 1548-1556
47. Lee Y.N., and Bieniasz P.D. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3 (2007) e10
48. Ono M., et al. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J. Virol. 60 (1996) 589-598
49. Seifarth W., et al. Retrovirus-like particles released from the human breast cancer cell line T47 D display type B and C related endogenous retroviral sequence. J. Virol. 69 (1995) 6408-6416
50. Patience C., et al. Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line. J. Virol. 70 (1996) 2654-2657
51. Boese A., et al. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 19 (2000) 4328-4336
52. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15 (2005) 179-211
53. Perron H., et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7583-7588
54. Blond J.L., et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 73 (1999) 1175-1185
55. Johnston J.B., et al. Monocyte activation and differentiation augment human endogenous retrovirus expression - implications for inflammatory brain diseases. Ann. Neurol. 50 (2001) 434-442
56. Conrad B., et al. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 90 (1997) 303-313
57. Badenhoop K., et al. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes 48 (1999) 215-218
58. Löwer R., et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 95 (1998) 11-14
59. Hsiao F.C., et al. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J. Immunol. 177 (2006) 2056-2060
60. Jaeckel E., et al. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes 48 (1999) 209-214
61. Knerr I., et al. Quantitation of gene expression by real-time PCR disproves a "retroviral hypothesis" for childhood-onset diabetes mellitus. Pediatr. Res. 46 (1999) 57-60
62. Muir A., et al. The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes 48 (1999) 219-222
63. Mamedov I., et al. A rare event of insertion polymorphism of a HERV-K LTR in the human genome. Genomics 84 (2004) 596-599
64. Bennett E.A., et al. Natural genetic variation caused by transposable elements in humans. Genetics 168 (2004) 933-951
65. Mayer J., et al. An almost-intact human endogenous retrovirus K on human chromosome 7. Nat. Genet. 21 (1999) 257-258
66. Barbulescu M., et al. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr. Biol. 9 (1999) 861-868
67. Kowalski P.E., and Mager D.L. A human endogenous retrovirus suppresses translation of an associated fusion transcript, PLA2L. J. Virol. 72 (1998) 6164-6168
68. Medstrand P., et al. Long terminal repeats are used as alternative promoters for the endothelin B receptor and apolipoprotein C-I genes in humans. J. Biol. Chem. 276 (2001) 1896-1903
69. Rolland A., et al. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J. Immunol. 176 (2006) 7636-7644
70. Mangeney M., et al. The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J. Gen. Virol. 82 (2001) 2515-2518